Apeloa Pharmaceutical (SHE:000739) unit Zhejiang Apeloa Tobang Pharmaceutical obtained marketing approval from China's drug regulator for the active pharmaceutical ingredient cefditoren pivoxil.
The API is used to treat respiratory, urinary, biliary, skin and soft tissue infections, as well as obstetric, gynecological, ophthalmic and dental infections, according to a Thursday filing with the Shenzhen bourse.
Shares of the pharmaceutical company slid 1% in recent trade.